Ensysce Shares Rally After FDA Feedback on Pain Medication

By Rob Curran Shares of Ensysce Biosciences rallied after the developer of pain medication intended to be less prone to abuse received feedback from the Food...

Related Keywords

San Diego ,California ,United States ,Lynn Kirkpatrick ,Ensysce Biosciences ,Rob Curran ,Drug Administration ,Chief Executive Lynn Kirkpatrick ,Article Normal ,Pharmaceuticals ,Analgesics ,Healthcare Life Sciences ,Specialized Drugs Medications ,Prescription Drugs ,Regulation Government Policy ,Financial Performance ,Corporate Industrial News ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Mensc ,Regulation ,Government Policy ,Corporate ,Industrial News ,Healthcare ,Life Sciences ,Specialized Drugs ,Medications ,